This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
Gynecologic Oncology Update
Claim This Podcastby Dr. Neil Love
4.5(16 reviews)
138 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
37
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality54
Social0
YouTube0
Engagement50
Podcast Overview
This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
Language
🇺🇲
Publishing Since
2/12/2008
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
37
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality54
Social0
YouTube0
Engagement50
6
Excellent Areas
2
Good Performance
11
Growth Opportunities
excellent
Episode Length
1h 15m
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 50 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Gynecologic Oncology Update
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
June 19, 2026
Ovarian Cancer — Fifth Annual National General Medical Oncology Summit
<p>Featuring perspectives from Dr Deborah K Armstrong and Dr David M O’Malley, including the following topics: </p><ul><li>Introduction (0:00)</li><li>PARP Inhibitors and Strategies Targeting Folate Receptor Alpha in Advanced Ovarian Cancer — Dr Armstrong (4:37)</li><li>Other Novel Agents and Strategies for the Treatment of Advanced Ovarian Cancer — Dr O’Malley (35:18)</li></ul><br/><p><u><a href="https://researchtopractice.com/GMO26/Video" rel="noopener noreferrer" target="_blank">CME information and select publications</a></u></p>
June 17, 2026
HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
<p>Featuring perspectives from Dr Joyce F Liu, Dr David M O’Malley and Dr Brian M Slomovitz, moderated by Dr O’Malley, including the following topics:</p><ul><li>Introduction (0:00)</li><li>Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Liu (2:52)</li><li>Available Data with and Practical Application of HER2-Targeted Therapy in Advanced Gynecologic Cancers — Dr Slomovitz (25:16)</li><li>Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr O’Malley (1:00:31)</li></ul><br/><p><u><a href="https://researchtopractice.com/SGO26HER2Gyn/Video" rel="noopener noreferrer" target="_blank">CME information and select publications</a></u></p>
June 3, 2026
Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
<p>Prof Ramez N Eskander from UC San Diego Moores Cancer Center in California, Dr Bradley J Monk from Florida Cancer Specialists & Research Institute in West Palm Beach and Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, review the treatment landscape of antibody-drug conjugate–directed therapy for gynecologic cancers and review recently presented clinical findings from the SGO 2026 Annual Meeting on Women’s Cancer.</p><p><u><a href="https://researchtopractice.com/activity/the-potential-role-of-trop2-and-cdh6-directed-antibody-drug-conjugates-in-gynecologic-cancers/" rel="noopener noreferrer" target="_blank">CME information and select publications</a></u></p>
138 total episodes available
Recent guests on Gynecologic Oncology Update
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Joyce F Liu
Guest
David M O’Malley
Guest
Ritu Salani
Guest
Alessandro D Santin
Guest
Courtney Arn
Guest
Jennifer Filipi
Guest
Dr Ritu Salani
Guest
Dr Brian Slomovitz
Guest
Kathryn Lyle
Guest
Jaclyn Shaver
Guest
Similar Podcasts
Discover related shows you might enjoy
IJGC conversations
ijgcgroup
Gastrointestinal Cancer Update
Dr. Neil Love
Prostate Cancer Update
Dr. Neil Love
Lung Cancer Update
Dr. Neil Love
Plenary Session
Vinay Prasad, MD MPH
All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
Oncology Today with Dr Neil Love
Dr. Neil Love
Research To Practice | Oncology Videos
Dr Neil Love
Two Onc Docs
Sam and Karine
Pivot
New York Magazine
Hematologic Oncology Update
Dr. Neil Love
The Mel Robbins Podcast
Mel Robbins
Hard Fork
The New York Times
ASCO Guidelines
American Society of Clinical Oncology (ASCO)
Deep-dive analytics for Gynecologic Oncology Update
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Gynecologic Oncology Update?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.